127 related articles for article (PubMed ID: 37846125)
21. HNRNPA2B1-mediated m
Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L
J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993
[TBL] [Abstract][Full Text] [Related]
22. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis.
Zhang X; Wu N; Wang J; Li Z
J Cell Mol Med; 2019 Oct; 23(10):6708-6719. PubMed ID: 31328388
[TBL] [Abstract][Full Text] [Related]
23. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
24. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
Liu Z; Chen JY; Zhong Y; Xie L; Li JS
Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
[TBL] [Abstract][Full Text] [Related]
25. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
Yin D; Lu X
Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778
[TBL] [Abstract][Full Text] [Related]
26. Tumor Inhibitory Effect of Long Non-coding RNA LOC100505817 on Gastric Cancer.
Zheng L; Kang L; Cheng Y; Cao J; Liu L; Xu H; Gao L
Pathol Oncol Res; 2021; 27():581542. PubMed ID: 34385891
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.
Zhang J; Yao T; Wang Y; Yu J; Liu Y; Lin Z
Cancer Biol Ther; 2016; 17(1):104-13. PubMed ID: 26574780
[TBL] [Abstract][Full Text] [Related]
28. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
[TBL] [Abstract][Full Text] [Related]
29. MEG3 Suppresses Human Pancreatic Neuroendocrine Tumor Cells Growth and Metastasis by Down-Regulation of Mir-183.
Zhang YY; Feng HM
Cell Physiol Biochem; 2017; 44(1):345-356. PubMed ID: 29132136
[TBL] [Abstract][Full Text] [Related]
30. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
31. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
32. MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer.
Xu G; Meng L; Yuan D; Li K; Zhang Y; Dang C; Zhu K
Oncol Rep; 2018 Jul; 40(1):39-48. PubMed ID: 29749532
[TBL] [Abstract][Full Text] [Related]
33. Participation of tumor suppressors long non-coding RNA MEG3, microRNA-377 and PTEN in glioma cell invasion and migration.
Wang D; Fu CW; Fan DQ
Pathol Res Pract; 2019 Oct; 215(10):152558. PubMed ID: 31378455
[TBL] [Abstract][Full Text] [Related]
34. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
35. MiR-208a enhances cell proliferation and invasion of gastric cancer by targeting SFRP1 and negatively regulating MEG3.
Cui HB; Ge HE; Wang YS; Bai XY
Int J Biochem Cell Biol; 2018 Sep; 102():31-39. PubMed ID: 29886152
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2.
Han H; Wang S; Meng J; Lyu G; Ding G; Hu Y; Wang L; Wu L; Yang W; Lv Y; Jia S; Zhang L; Ji J
Oncogene; 2020 Oct; 39(42):6513-6528. PubMed ID: 32901105
[TBL] [Abstract][Full Text] [Related]
37. lncRNA SNHG11 Promotes Gastric Cancer Progression by Activating the Wnt/β-Catenin Pathway and Oncogenic Autophagy.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Ther; 2021 Mar; 29(3):1258-1278. PubMed ID: 33068778
[TBL] [Abstract][Full Text] [Related]
38. MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1.
Yan J; Guo X; Xia J; Shan T; Gu C; Liang Z; Zhao W; Jin S
Med Oncol; 2014 Mar; 31(3):879. PubMed ID: 24515776
[TBL] [Abstract][Full Text] [Related]
39. The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells.
Tao Y; Yue P; Miao Y; Gao S; Wang B; Leng SX; Meng X; Zhang H
J Gene Med; 2021 Feb; 23(2):e3291. PubMed ID: 33141998
[TBL] [Abstract][Full Text] [Related]
40. The Role of LncRNA NEAT1 in Gastric Cancer: Tumor Development and Potential Therapeutic Target.
Zhang Y; Wen Y
Curr Pharm Des; 2023; 29(28):2213-2222. PubMed ID: 37779403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
